Clinical Trial

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 15, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with liposarcoma who partake in a separate clinical research featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical study, individuals have the unique opportunity to contribute to the betterment of future liposarcoma patients and play an active role in advancing medical research.
Trial Details
NCT Number NCT06039046
Lead Sponsor Power Life Sciences Inc.
Conditions Liposarcoma
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-15